Consolidated figures · ₹ crore
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 684 | 684 | 4,949 | 4,773 | 4,136 | 4,178 | 4,388 | |
| COGS | 354 | 370 | 2,794 | 2,582 | 2,143 | 2,107 | 2,295 |
| Gross profit | 330 | 314 | 2,155 | 2,191 | 1,993 | 2,070 | 2,093 |
| -383 | 197 | 1,323 | 1,644 | 1,572 | 1,551 | 1,526 | |
| 713 | 117 | 832 | 547 | 421 | 519 | 567 | |
| OPM % | 104.3% | 17.1% | 16.8% | 11.5% | 10.2% | 12.4% | 12.9% |
| Depreciation | 22 | 22 | 123 | 122 | 136 | 158 | 175 |
| Interest | 7 | 7 | 31 | 22 | 53 | 56 | 49 |
| 16 | -10 | 31 | 33 | 35 | 38 | 27 | |
| Profit before tax | -0 | 77 | 709 | 437 | 268 | 344 | 370 |
| Tax | — | 23 | 232 | 129 | 85 | 92 | 92 |
| Tax % | — | 29.8% | 32.8% | 29.6% | 31.7% | 26.9% | 24.8% |
| -0 | 54 | 477 | 308 | 183 | 251 | 278 | |
| PAT margin % | -0% | 8% | 9.6% | 6.4% | 4.4% | 6% | 6.3% |
| EPS (₹) | -3.3 | 20.8 | 30 | 19.3 | 11.6 | 15.9 | 17.6 |
| EPS adjusted (₹) | — | 3.4 | 30 | 19.3 | 11.6 | 15.9 | 17.6 |
| — | 1.7% | 16.7% | 25.9% | 43.3% | 31.5% | 28.4% | |
| Annual report | — | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 | 3,110 |
| 546 | 229 | 397 | 733 | 764 | 792 | |
| 910 | 1,135 | 1,196 | 1,261 | 1,341 | 1,566 | |
| Total equity & liabilities | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 | 5,484 |
| 1,756 | 1,755 | 1,846 | 2,497 | 2,581 | 3,183 | |
| CWIP | 63 | 169 | 525 | 331 | 525 | 154 |
| Investments | 50 | 6 | 8 | 16 | 37 | 33 |
| 1,509 | 1,867 | 1,880 | 1,888 | 1,889 | 2,113 | |
| Total assets | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 | 5,484 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Speciality Chemicals | 2,214.26 | 410.38 | 2,954.02 | 646.27 | 2,307.75 | 17.78 |
| Chemical Intermediates | 1,667.98 | 18.91 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 112 | 453 | 462 | 430 | 508 | 524 | |
| -44 | -72 | -472 | -569 | -393 | -276 | |
| -72 | -418 | 42 | 144 | -129 | -155 | |
| Net cash flow | -4 | -37 | 32 | 5 | -13 | 93 |
| Free cash flow | 85 | 223 | -19 | -138 | 142 | 225 |
| CFO / Operating profit % | 95.9% | 54.4% | 84.5% | 102.1% | 97.9% | 92.5% |
| 1,438.84 |
| 530.17 |
| 908.67 |
| 2.08 |
| Nutrition & Health Solutions | 790.4 | 79.42 | 803.08 | 146.86 | 656.22 | 12.1 |
₹ crore by fiscal year